Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Integral Health Asset Management LLC

Integral Health Asset Management LLC lifted its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,000,000 shares of the company's stock after acquiring an additional 200,000 shares during the period. Integral Health Asset Management LLC owned 0.90% of Sana Biotechnology worth $3,260,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. China Universal Asset Management Co. Ltd. grew its position in Sana Biotechnology by 10.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 47,341 shares of the company's stock worth $77,000 after purchasing an additional 4,554 shares during the period. Teacher Retirement System of Texas grew its position in Sana Biotechnology by 20.3% during the 4th quarter. Teacher Retirement System of Texas now owns 36,797 shares of the company's stock worth $60,000 after purchasing an additional 6,209 shares during the period. Blue Trust Inc. grew its position in Sana Biotechnology by 51.0% during the 4th quarter. Blue Trust Inc. now owns 19,823 shares of the company's stock worth $32,000 after purchasing an additional 6,694 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in Sana Biotechnology during the 3rd quarter worth about $29,000. Finally, Charles Schwab Investment Management Inc. grew its position in Sana Biotechnology by 0.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,056,512 shares of the company's stock worth $1,722,000 after purchasing an additional 8,666 shares during the period. 88.23% of the stock is owned by institutional investors and hedge funds.

Sana Biotechnology Price Performance

Sana Biotechnology stock traded down $0.02 during midday trading on Wednesday, reaching $1.78. The company had a trading volume of 2,748,997 shares, compared to its average volume of 3,342,704. The company has a market capitalization of $401.35 million, a P/E ratio of -1.27 and a beta of 1.75. Sana Biotechnology, Inc. has a 12-month low of $1.26 and a 12-month high of $9.49. The firm's fifty day simple moving average is $1.89 and its 200-day simple moving average is $2.45.

Sana Biotechnology (NASDAQ:SANA - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.20) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.02. On average, analysts expect that Sana Biotechnology, Inc. will post -1.16 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on SANA shares. HC Wainwright restated a "buy" rating and set a $11.00 target price on shares of Sana Biotechnology in a research report on Thursday, April 24th. Citizens Jmp upgraded Sana Biotechnology from a "market perform" rating to an "outperform" rating and set a $5.00 target price on the stock in a research report on Tuesday, March 18th. Finally, Jefferies Financial Group initiated coverage on Sana Biotechnology in a research report on Friday, March 14th. They set a "buy" rating and a $7.00 target price on the stock. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $10.80.

About Sana Biotechnology

Sana Biotechnology, Inc, a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others.